Current issues in Hereditary Angioedema (HAE) - Ipopi
Current issues in Hereditary Angioedema (HAE) - Ipopi
Current issues in Hereditary Angioedema (HAE) - Ipopi
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
• Ber<strong>in</strong>ert (C1 <strong>in</strong>hibitor)<br />
trials<br />
– 20 U/kg (ie at least 3 vials)<br />
– Much quicker response<br />
and recovery at this dose<br />
– Recommend this dose for<br />
most people<br />
– esp. extensive, established<br />
or laryngeal attacks<br />
– [May be able to use lower<br />
doses for self<br />
adm<strong>in</strong>istration, or v<br />
t<strong>in</strong>y/early swell<strong>in</strong>gs]
Change language